10 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 10 of 10 clinical reviews.
Structured exercise programs reduce OSA severity by 25-50% even without weight loss. Review the evidence on aerobic, resistance, and oropharyngeal training protocols for AHI reduction.
A complete walkthrough of the OSA diagnostic algorithm: screening tools, home vs. Lab sleep testing, AHI thresholds, severity classification, and first-line treatment options including CPAP, weight loss, and tirzepatide (Zepbound).
A look at emerging OSA research, including tirzepatide's FDA-approved role, positive airway pressure, endotypes, devices, and diagnostic advances.
How OSA diagnosis and first-line treatment differ across pregnant women, children, older adults, people with obesity, and people with cardiovascular disease or diabetes, including where tirzepatide and CPAP fit and where the evidence is still incomplete.
Obstructive sleep apnea rarely travels alone. Learn which comorbidities overlap most with OSA, how they interact, and what the clinical evidence says about managing them together.
Obstructive sleep apnea has a strong genetic component. Learn how family history, inherited craniofacial traits, and specific gene variants increase OSA risk, and what screening steps to take.
Evidence-based nutrition, weight-management, and lifestyle interventions for obstructive sleep apnea (OSA), including dietary patterns, GLP-1 receptor agonists, exercise protocols, and positional therapy.
Evidence-based OSA treatment algorithm organized by line of therapy, from CPAP and oral appliances to tirzepatide and surgical options, with AHI-based staging and trial data.
Sleep apnea follow-up care: CPAP check at 30 days, clinical review at 3 months, then every 6-12 months with annual cardiometabolic screening.
Endocrine Society advises against testosterone therapy in untreated severe OSA. See this rule alongside ADA, AACE, AASM, and USPSTF guidance compared.